{"id":65,"date":"2021-05-22T00:32:47","date_gmt":"2021-05-22T04:32:47","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/?post_type=chapter&#038;p=65"},"modified":"2022-01-12T23:06:10","modified_gmt":"2022-01-13T04:06:10","slug":"subgroups-were-additional-comparisons-made-on-segments-of-the-study-population","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/chapter\/subgroups-were-additional-comparisons-made-on-segments-of-the-study-population\/","title":{"raw":"Subgroups analysis: Were additional comparisons made on segments of the study population?","rendered":"Subgroups analysis: Were additional comparisons made on segments of the study population?"},"content":{"raw":"Most [pb_glossary id=\"704\"]RCT[\/pb_glossary] publications report on additional analyses of subgroups from the overall trial population (e.g. examining only participants with diabetes, or only those age &gt;70 years). In theory, such analyses could uncover more individualized treatment effects; however, in practice they are much more likely to be spurious and irreproducible, and therefore misleading. Subgroup analyses are often performed (and emphasized in publications) when studies do not find a statistically significant difference in the overall study population. Therefore, subgroup analysis is often a form of data-mining.\r\n<h1>Checklist Questions<\/h1>\r\n<table class=\"grid\" style=\"border-collapse: collapse;width: 100%;height: 172px\" border=\"0\">\r\n<tbody>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Are statistically significant results in a subgroup being emphasized in the context of a neutral or negative trial?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Was the subgroup analysis pre-defined?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Was the direction of the subgroup effect pre-defined?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Was the subgroup analysis one of a small number of hypotheses tested?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Is the subgroup variable a characteristic measured at baseline or after randomization?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Could treatment effect differences between subgroups be attributable to baseline imbalances?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 10px\">\r\n<td style=\"width: 100%;height: 10px\">Is the subgroup effect statistically significant?<\/td>\r\n<\/tr>\r\n<tr style=\"height: 18px\">\r\n<td style=\"width: 100%;height: 18px\">Is the subgroup effect consistent within and across trials?<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"width: 100%\">[[pb_glossary id=\"1099\"]Systematic reviews[\/pb_glossary]\/[pb_glossary id=\"1101\"]meta-analyses[\/pb_glossary] only] Is the effect suggested by comparisons within rather than between studies?<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h1>Are statistically significant results in a subgroup being emphasized in the context of a neutral or negative trial?<\/h1>\r\n<span class=\"TextRun SCXW47292663 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW47292663 BCX9\">Subgroup analyses can be used for <\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2 SCXW47292663 BCX9\">data-mining<\/span><span class=\"NormalTextRun SCXW47292663 BCX9\"> when overall results are not statistically significantly different <\/span><\/span><span class=\"EOP SCXW47292663 BCX9\" data-ccp-props=\"{}\">and may be highlighted when the [pb_glossary id=\"1517\"]primary endpoint[\/pb_glossary] fails to cross the threshold of statistical significance.<\/span>\r\n<h1>Was the subgroup analysis pre-defined?<\/h1>\r\nSubgroup analyses that were not pre-defined in the protocol may be a form of data-mining, and are vulnerable to finding a difference by chance. Avoid making clinical decisions based on unanticipated significant subgroup differences (i.e. discovered post hoc) until they have been replicated in other studies.\r\n\r\nThis is particular concerning for continuous variables, such as age or cholesterol level, that are dichotomized via non-prespecified cutoffs (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Schandelmaier S et al.<\/a>). For example, LDL cholesterol could be dichotomized via numerous arbitrary cutoffs (e.g. &gt;3.5, &gt;4.0...). If not pre-specified, such cutoffs could be selected by whichever value showed the most impressive or statistically significant result. Such data-mining efforts are unlikely to uncover true subgroup differences.\r\n<h1>Was the direction of the subgroup effect correctly pre-defined?<\/h1>\r\n<span class=\"TextRun SCXW123271780 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW123271780 BCX9\">Subgroup effects that are significant but go in the direction opposite to what was hypothesized are less credible than correct predictions.<\/span><\/span><span class=\"EOP SCXW123271780 BCX9\" data-ccp-props=\"{}\">\u00a0<\/span>\r\n<h1>Was the subgroup analysis one of a small number of hypotheses tested?<\/h1>\r\n<span class=\"TextRun SCXW201799321 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW201799321 BCX9\">More comparisons increase the likelihood of finding a difference by chance.<\/span><\/span><span class=\"EOP SCXW201799321 BCX9\" data-ccp-props=\"{}\"> See the multiplicity discussion <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/chapter\/secondary-outcomes-can-conclusions-be-made-from-outcomes-other-than-the-primary-one\/\" target=\"_blank\" rel=\"noopener\">here<\/a> for more information.<\/span>\r\n<h1>Is the subgroup variable a characteristic measured at baseline or after randomization?<\/h1>\r\nSubgroup analyses of variables measured after randomization may be affected by the interventions, thereby introducing <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounding<\/a>.\r\n<div class=\"textbox shaded\">\r\n\r\n<em>Examples of variables measured at baseline: <\/em>\r\n<ul>\r\n \t<li><em>Age<\/em><\/li>\r\n \t<li><em>Sex<\/em><\/li>\r\n \t<li><em>Pre-treatment LDL cholesterol.<\/em><\/li>\r\n<\/ul>\r\n<em>Examples of variables measured after randomization: <\/em>\r\n<ul>\r\n \t<li><em>LDL cholesterol achieved after 12 weeks of study intervention in fixed-dose statin trial<\/em><\/li>\r\n \t<li><em>Success of revascularization in a trial comparing coronary artery bypass grafting surgery to percutaneous coronary intervention in coronary artery disease<\/em><\/li>\r\n<\/ul>\r\n<\/div>\r\n<h1>Could treatment effect differences between subgroups be attributable to baseline imbalances?<\/h1>\r\nRandomization ensures that <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounders<\/a> have equal probability of being distributed across intervention groups, but does not guarantee balance between subgroups. Subgroups are prone to imbalances of potential <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounders<\/a>, especially when these subgroups contain a small number of participants.\r\n\r\nThe exception is when [pb_glossary id=\"135\"]randomization is stratified[\/pb_glossary] for the variable that defines the subgroups (e.g. stratified randomization by history of diabetes). In the case of a stratified subgroup, there is a reduced risk of <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounder<\/a> imbalance.\r\n<h1>Is the subgroup effect statistically significant?<\/h1>\r\n<div style=\"font-weight: 400\">\r\n\r\nA review of 117 subgroup claims in 64 [pb_glossary id=\"704\"]RCTs[\/pb_glossary] found that less than 40% of subgroup claims reported in the abstract were statistically significant (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Wallach JD et al.<\/a>).\r\n\r\n<\/div>\r\n<div style=\"font-weight: 400\">\r\n\r\nStatistical significance is determined by examining the <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p-value<\/a> for the test for interaction (which tests whether treatment effect differs across subgroups), not the <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p-value<\/a> or 95% <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">CI<\/a> within a subgroup (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Brookes ST et al.<\/a>). \u201cPositive\u201d subgroup analyses that do not report the test for interaction <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p-value<\/a> should be ignored.\r\n<div class=\"textbox shaded\"><em>E.g. In HPS (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Heart Protection Study Collaborative Group<\/a>), subgroup analysis based on sex (1 of 17 subgroup analyses reported) did not show a statistically significant test for interaction (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p<\/a>=0.18), meaning that the overall trial results applied to both males and females.<\/em><\/div>\r\n<\/div>\r\n<h1>Is the subgroup effect consistent within and across trials?<\/h1>\r\n<div>Within a trial, consistent subgroup effect across multiple related outcomes (e.g. myocardial infarction, ischemic stroke and cardiovascular death) increases the credibility of there being a true subgroup effect.<\/div>\r\n<div class=\"textbox shaded\"><em><span class=\"TextRun SCXW147949717 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2 SCXW147949717 BCX9\">E.g.<\/span><span class=\"NormalTextRun SCXW147949717 BCX9\"> Myocardial infarction, <\/span><\/span><span class=\"TextRun SCXW147949717 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147949717 BCX9\">ischemic\u00a0<\/span><\/span><span class=\"TextRun SCXW147949717 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147949717 BCX9\">stroke, and cardiovascular death all being similarly reduced by an intervention on a subgroup of patients with diabetes.<\/span><\/span><\/em><\/div>\r\n<span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">A true subgroup effect is also more likely if additional studies replicate the effect; however, this rarely occurs. One review <\/span><\/span><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">f<\/span><\/span><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">ound <\/span><\/span><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">that only approximately 10% of positive subgroup analyses were replicated in a subsequent trial designed to confirm the effect within the subgroup (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\">Wallach JD et al.<\/a>).<\/span><\/span>\r\n<h1>[Systematic Reviews\/Meta-Analyses Only] Is the effect suggested by comparisons within rather than between studies?<\/h1>\r\nSubgroup effects identified between studies, such as in two trials in a [pb_glossary id=\"1099\"]systematic review[\/pb_glossary], may be due to methodological or clinical differences between trials rather than true associations with the different subgroups\r\n<div class=\"textbox shaded\"><em>E.g. The Physicians\u2019 Health Study (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Steering Committee of the Physicians\u2019 Health Study Research Group<\/a>), a study of men without previous cardiovascular disease, found that low-dose ASA statistically-significantly reduced the risk of myocardial infarction but not stroke. Many years later, the Women\u2019s Health Study demonstrated a statistically significant reduction in stroke but not myocardial infarction with ASA in women without previous cardiovascular disease. It would be inappropriate to conclude based on an indirect comparison of these two [pb_glossary id=\"704\"]RCTs[\/pb_glossary] that ASA has different benefits in men compared with women.\u00a0<\/em><\/div>","rendered":"<p>Most <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_704\">RCT<\/a> publications report on additional analyses of subgroups from the overall trial population (e.g. examining only participants with diabetes, or only those age &gt;70 years). In theory, such analyses could uncover more individualized treatment effects; however, in practice they are much more likely to be spurious and irreproducible, and therefore misleading. Subgroup analyses are often performed (and emphasized in publications) when studies do not find a statistically significant difference in the overall study population. Therefore, subgroup analysis is often a form of data-mining.<\/p>\n<h1>Checklist Questions<\/h1>\n<table class=\"grid\" style=\"border-collapse: collapse;width: 100%;height: 172px\">\n<tbody>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Are statistically significant results in a subgroup being emphasized in the context of a neutral or negative trial?<\/td>\n<\/tr>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Was the subgroup analysis pre-defined?<\/td>\n<\/tr>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Was the direction of the subgroup effect pre-defined?<\/td>\n<\/tr>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Was the subgroup analysis one of a small number of hypotheses tested?<\/td>\n<\/tr>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Is the subgroup variable a characteristic measured at baseline or after randomization?<\/td>\n<\/tr>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Could treatment effect differences between subgroups be attributable to baseline imbalances?<\/td>\n<\/tr>\n<tr style=\"height: 10px\">\n<td style=\"width: 100%;height: 10px\">Is the subgroup effect statistically significant?<\/td>\n<\/tr>\n<tr style=\"height: 18px\">\n<td style=\"width: 100%;height: 18px\">Is the subgroup effect consistent within and across trials?<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 100%\">[<a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_1099\">Systematic reviews<\/a>\/<a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_1101\">meta-analyses<\/a> only] Is the effect suggested by comparisons within rather than between studies?<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1>Are statistically significant results in a subgroup being emphasized in the context of a neutral or negative trial?<\/h1>\n<p><span class=\"TextRun SCXW47292663 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW47292663 BCX9\">Subgroup analyses can be used for <\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2 SCXW47292663 BCX9\">data-mining<\/span><span class=\"NormalTextRun SCXW47292663 BCX9\"> when overall results are not statistically significantly different <\/span><\/span><span class=\"EOP SCXW47292663 BCX9\" data-ccp-props=\"{}\">and may be highlighted when the <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_1517\">primary endpoint<\/a> fails to cross the threshold of statistical significance.<\/span><\/p>\n<h1>Was the subgroup analysis pre-defined?<\/h1>\n<p>Subgroup analyses that were not pre-defined in the protocol may be a form of data-mining, and are vulnerable to finding a difference by chance. Avoid making clinical decisions based on unanticipated significant subgroup differences (i.e. discovered post hoc) until they have been replicated in other studies.<\/p>\n<p>This is particular concerning for continuous variables, such as age or cholesterol level, that are dichotomized via non-prespecified cutoffs (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Schandelmaier S et al.<\/a>). For example, LDL cholesterol could be dichotomized via numerous arbitrary cutoffs (e.g. &gt;3.5, &gt;4.0&#8230;). If not pre-specified, such cutoffs could be selected by whichever value showed the most impressive or statistically significant result. Such data-mining efforts are unlikely to uncover true subgroup differences.<\/p>\n<h1>Was the direction of the subgroup effect correctly pre-defined?<\/h1>\n<p><span class=\"TextRun SCXW123271780 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW123271780 BCX9\">Subgroup effects that are significant but go in the direction opposite to what was hypothesized are less credible than correct predictions.<\/span><\/span><span class=\"EOP SCXW123271780 BCX9\" data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h1>Was the subgroup analysis one of a small number of hypotheses tested?<\/h1>\n<p><span class=\"TextRun SCXW201799321 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW201799321 BCX9\">More comparisons increase the likelihood of finding a difference by chance.<\/span><\/span><span class=\"EOP SCXW201799321 BCX9\" data-ccp-props=\"{}\"> See the multiplicity discussion <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/chapter\/secondary-outcomes-can-conclusions-be-made-from-outcomes-other-than-the-primary-one\/\" target=\"_blank\" rel=\"noopener\">here<\/a> for more information.<\/span><\/p>\n<h1>Is the subgroup variable a characteristic measured at baseline or after randomization?<\/h1>\n<p>Subgroup analyses of variables measured after randomization may be affected by the interventions, thereby introducing <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounding<\/a>.<\/p>\n<div class=\"textbox shaded\">\n<p><em>Examples of variables measured at baseline: <\/em><\/p>\n<ul>\n<li><em>Age<\/em><\/li>\n<li><em>Sex<\/em><\/li>\n<li><em>Pre-treatment LDL cholesterol.<\/em><\/li>\n<\/ul>\n<p><em>Examples of variables measured after randomization: <\/em><\/p>\n<ul>\n<li><em>LDL cholesterol achieved after 12 weeks of study intervention in fixed-dose statin trial<\/em><\/li>\n<li><em>Success of revascularization in a trial comparing coronary artery bypass grafting surgery to percutaneous coronary intervention in coronary artery disease<\/em><\/li>\n<\/ul>\n<\/div>\n<h1>Could treatment effect differences between subgroups be attributable to baseline imbalances?<\/h1>\n<p>Randomization ensures that <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounders<\/a> have equal probability of being distributed across intervention groups, but does not guarantee balance between subgroups. Subgroups are prone to imbalances of potential <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounders<\/a>, especially when these subgroups contain a small number of participants.<\/p>\n<p>The exception is when <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_135\">randomization is stratified<\/a> for the variable that defines the subgroups (e.g. stratified randomization by history of diabetes). In the case of a stratified subgroup, there is a reduced risk of <a href=\"https:\/\/catalogofbias.org\/biases\/confounding\/\" target=\"_blank\" rel=\"noopener\">confounder<\/a> imbalance.<\/p>\n<h1>Is the subgroup effect statistically significant?<\/h1>\n<div style=\"font-weight: 400\">\n<p>A review of 117 subgroup claims in 64 <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_704\">RCTs<\/a> found that less than 40% of subgroup claims reported in the abstract were statistically significant (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Wallach JD et al.<\/a>).<\/p>\n<\/div>\n<div style=\"font-weight: 400\">\n<p>Statistical significance is determined by examining the <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p-value<\/a> for the test for interaction (which tests whether treatment effect differs across subgroups), not the <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p-value<\/a> or 95% <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">CI<\/a> within a subgroup (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Brookes ST et al.<\/a>). \u201cPositive\u201d subgroup analyses that do not report the test for interaction <a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p-value<\/a> should be ignored.<\/p>\n<div class=\"textbox shaded\"><em>E.g. In HPS (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Heart Protection Study Collaborative Group<\/a>), subgroup analysis based on sex (1 of 17 subgroup analyses reported) did not show a statistically significant test for interaction (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/appendix\/\" target=\"_blank\" rel=\"noopener\">p<\/a>=0.18), meaning that the overall trial results applied to both males and females.<\/em><\/div>\n<\/div>\n<h1>Is the subgroup effect consistent within and across trials?<\/h1>\n<div>Within a trial, consistent subgroup effect across multiple related outcomes (e.g. myocardial infarction, ischemic stroke and cardiovascular death) increases the credibility of there being a true subgroup effect.<\/div>\n<div class=\"textbox shaded\"><em><span class=\"TextRun SCXW147949717 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2 SCXW147949717 BCX9\">E.g.<\/span><span class=\"NormalTextRun SCXW147949717 BCX9\"> Myocardial infarction, <\/span><\/span><span class=\"TextRun SCXW147949717 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147949717 BCX9\">ischemic\u00a0<\/span><\/span><span class=\"TextRun SCXW147949717 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147949717 BCX9\">stroke, and cardiovascular death all being similarly reduced by an intervention on a subgroup of patients with diabetes.<\/span><\/span><\/em><\/div>\n<p><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">A true subgroup effect is also more likely if additional studies replicate the effect; however, this rarely occurs. One review <\/span><\/span><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">f<\/span><\/span><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">ound <\/span><\/span><span class=\"TextRun Highlight SCXW19987928 BCX9\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW19987928 BCX9\">that only approximately 10% of positive subgroup analyses were replicated in a subsequent trial designed to confirm the effect within the subgroup (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\">Wallach JD et al.<\/a>).<\/span><\/span><\/p>\n<h1>[Systematic Reviews\/Meta-Analyses Only] Is the effect suggested by comparisons within rather than between studies?<\/h1>\n<p>Subgroup effects identified between studies, such as in two trials in a <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_1099\">systematic review<\/a>, may be due to methodological or clinical differences between trials rather than true associations with the different subgroups<\/p>\n<div class=\"textbox shaded\"><em>E.g. The Physicians\u2019 Health Study (<a href=\"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/back-matter\/references\/\" target=\"_blank\" rel=\"noopener\">Steering Committee of the Physicians\u2019 Health Study Research Group<\/a>), a study of men without previous cardiovascular disease, found that low-dose ASA statistically-significantly reduced the risk of myocardial infarction but not stroke. Many years later, the Women\u2019s Health Study demonstrated a statistically significant reduction in stroke but not myocardial infarction with ASA in women without previous cardiovascular disease. It would be inappropriate to conclude based on an indirect comparison of these two <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_65_704\">RCTs<\/a> that ASA has different benefits in men compared with women.\u00a0<\/em><\/div>\n<div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_65_704\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_65_704\"><div tabindex=\"-1\"><p>Randomized controlled trials are those in which participants are randomly allocated to two or more groups which are given different treatments.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_65_1099\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_65_1099\"><div tabindex=\"-1\"><p>A review that systematically identifies all potentially relevant studies on a research question. The aggregate of studies is then evaluated with respect to factors such as risk of bias of individual studies or heterogeneity among results. The qualitative combination of results is a systematic review.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_65_1101\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_65_1101\"><div tabindex=\"-1\"><p>A meta-analysis is a quantitative combination of the data obtained in a systematic review.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_65_1517\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_65_1517\"><div tabindex=\"-1\"><p>A primary outcome is an outcome from which trial design choices are based (e.g. sample size calculations). Primary outcomes are not necessarily the most important outcomes.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_65_135\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_65_135\"><div tabindex=\"-1\"><p>A multistage approach to randomization in which participants are initially allocated to strata based on certain defined commonalities (e.g. stratified according to LDL levels). After stratification these participants are then randomized within their respective stratum.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":1318,"menu_order":7,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[],"contributor":[],"license":[],"class_list":["post-65","chapter","type-chapter","status-publish","hentry"],"part":3,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/chapters\/65","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/wp\/v2\/users\/1318"}],"version-history":[{"count":26,"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/chapters\/65\/revisions"}],"predecessor-version":[{"id":1889,"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/chapters\/65\/revisions\/1889"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/parts\/3"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/chapters\/65\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/wp\/v2\/media?parent=65"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/pressbooks\/v2\/chapter-type?post=65"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/wp\/v2\/contributor?post=65"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/rickyturgeon\/wp-json\/wp\/v2\/license?post=65"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}